nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—MET—periodontitis	0.393	0.545	CbGaD
Crizotinib—NTRK1—periodontitis	0.327	0.454	CbGaD
Crizotinib—LTK—tongue—periodontitis	0.00317	0.0294	CbGeAlD
Crizotinib—SRC—periosteum—periodontitis	0.00307	0.0284	CbGeAlD
Crizotinib—CSF1R—periosteum—periodontitis	0.00276	0.0255	CbGeAlD
Crizotinib—LTK—mouth—periodontitis	0.00214	0.0198	CbGeAlD
Crizotinib—NTRK1—trigeminal ganglion—periodontitis	0.00199	0.0184	CbGeAlD
Crizotinib—MET—mouth—periodontitis	0.00194	0.0179	CbGeAlD
Crizotinib—TIE1—endothelium—periodontitis	0.00192	0.0177	CbGeAlD
Crizotinib—EPHA4—tongue—periodontitis	0.00175	0.0162	CbGeAlD
Crizotinib—MET—neck—periodontitis	0.00165	0.0153	CbGeAlD
Crizotinib—RIPK2—endothelium—periodontitis	0.00158	0.0146	CbGeAlD
Crizotinib—NEK9—connective tissue—periodontitis	0.00157	0.0145	CbGeAlD
Crizotinib—PTK2—endothelium—periodontitis	0.00146	0.0135	CbGeAlD
Crizotinib—FES—parotid gland—periodontitis	0.00143	0.0132	CbGeAlD
Crizotinib—SIK2—connective tissue—periodontitis	0.00141	0.013	CbGeAlD
Crizotinib—LIMK2—mouth—periodontitis	0.00136	0.0126	CbGeAlD
Crizotinib—EPHB4—endothelium—periodontitis	0.00133	0.0123	CbGeAlD
Crizotinib—IGF1R—neck—periodontitis	0.0013	0.012	CbGeAlD
Crizotinib—TEK—endothelium—periodontitis	0.00127	0.0118	CbGeAlD
Crizotinib—MAPK7—connective tissue—periodontitis	0.00127	0.0117	CbGeAlD
Crizotinib—DCLK1—trigeminal ganglion—periodontitis	0.00125	0.0116	CbGeAlD
Crizotinib—MET—connective tissue—periodontitis	0.00119	0.011	CbGeAlD
Crizotinib—EPHA4—mouth—periodontitis	0.00118	0.0109	CbGeAlD
Crizotinib—FER—trigeminal ganglion—periodontitis	0.00117	0.0108	CbGeAlD
Crizotinib—EPHA5—trigeminal ganglion—periodontitis	0.00117	0.0108	CbGeAlD
Crizotinib—TNK1—trigeminal ganglion—periodontitis	0.00116	0.0107	CbGeAlD
Crizotinib—CDK7—connective tissue—periodontitis	0.00115	0.0106	CbGeAlD
Crizotinib—SRC—endothelium—periodontitis	0.00113	0.0105	CbGeAlD
Crizotinib—PTK2—mouth—periodontitis	0.00113	0.0104	CbGeAlD
Crizotinib—MET—epithelium—periodontitis	0.00113	0.0104	CbGeAlD
Crizotinib—MAP4K2—trigeminal ganglion—periodontitis	0.00111	0.0102	CbGeAlD
Crizotinib—BMP2K—neck—periodontitis	0.00109	0.01	CbGeAlD
Crizotinib—TESK1—trigeminal ganglion—periodontitis	0.00106	0.00977	CbGeAlD
Crizotinib—JAK3—connective tissue—periodontitis	0.00105	0.00968	CbGeAlD
Crizotinib—STK4—connective tissue—periodontitis	0.00103	0.0095	CbGeAlD
Crizotinib—NUAK2—trigeminal ganglion—periodontitis	0.001	0.00926	CbGeAlD
Crizotinib—TESK1—parotid gland—periodontitis	0.000996	0.00921	CbGeAlD
Crizotinib—ACVR1—trigeminal ganglion—periodontitis	0.000994	0.0092	CbGeAlD
Crizotinib—MAP3K12—trigeminal ganglion—periodontitis	0.000994	0.0092	CbGeAlD
Crizotinib—TYRO3—connective tissue—periodontitis	0.00097	0.00898	CbGeAlD
Crizotinib—ALK—connective tissue—periodontitis	0.00097	0.00898	CbGeAlD
Crizotinib—TBK1—neck—periodontitis	0.000965	0.00893	CbGeAlD
Crizotinib—PTK2—neck—periodontitis	0.000965	0.00893	CbGeAlD
Crizotinib—LYN—connective tissue—periodontitis	0.000965	0.00893	CbGeAlD
Crizotinib—NUAK2—parotid gland—periodontitis	0.000944	0.00874	CbGeAlD
Crizotinib—ACVR1—parotid gland—periodontitis	0.000937	0.00867	CbGeAlD
Crizotinib—BMP2K—trigeminal ganglion—periodontitis	0.000937	0.00867	CbGeAlD
Crizotinib—IGF1R—connective tissue—periodontitis	0.000932	0.00862	CbGeAlD
Crizotinib—RPS6KB1—neck—periodontitis	0.000929	0.00859	CbGeAlD
Crizotinib—BMPR1B—epithelium—periodontitis	0.000902	0.00835	CbGeAlD
Crizotinib—RIPK2—trigeminal ganglion—periodontitis	0.000898	0.00831	CbGeAlD
Crizotinib—IGF1R—epithelium—periodontitis	0.000885	0.00819	CbGeAlD
Crizotinib—TESK1—connective tissue—periodontitis	0.000876	0.00811	CbGeAlD
Crizotinib—TIE1—epithelium—periodontitis	0.000861	0.00797	CbGeAlD
Crizotinib—RIPK2—parotid gland—periodontitis	0.000847	0.00784	CbGeAlD
Crizotinib—TBK1—trigeminal ganglion—periodontitis	0.000834	0.00771	CbGeAlD
Crizotinib—TYK2—trigeminal ganglion—periodontitis	0.000828	0.00766	CbGeAlD
Crizotinib—ACVR1—connective tissue—periodontitis	0.000825	0.00763	CbGeAlD
Crizotinib—FLT3—connective tissue—periodontitis	0.000825	0.00763	CbGeAlD
Crizotinib—RPS6KB1—trigeminal ganglion—periodontitis	0.000802	0.00742	CbGeAlD
Crizotinib—LCK—trigeminal ganglion—periodontitis	0.000797	0.00737	CbGeAlD
Crizotinib—AXL—trigeminal ganglion—periodontitis	0.000794	0.00734	CbGeAlD
Crizotinib—TBK1—parotid gland—periodontitis	0.000786	0.00727	CbGeAlD
Crizotinib—TYK2—parotid gland—periodontitis	0.000781	0.00723	CbGeAlD
Crizotinib—BMP2K—connective tissue—periodontitis	0.000778	0.0072	CbGeAlD
Crizotinib—SLK—trigeminal ganglion—periodontitis	0.000764	0.00707	CbGeAlD
Crizotinib—EPHB4—trigeminal ganglion—periodontitis	0.000759	0.00702	CbGeAlD
Crizotinib—RPS6KB1—parotid gland—periodontitis	0.000756	0.007	CbGeAlD
Crizotinib—JAK2—trigeminal ganglion—periodontitis	0.000753	0.00697	CbGeAlD
Crizotinib—PTK2B—connective tissue—periodontitis	0.000751	0.00695	CbGeAlD
Crizotinib—RIPK2—connective tissue—periodontitis	0.000745	0.0069	CbGeAlD
Crizotinib—EPHA2—trigeminal ganglion—periodontitis	0.000744	0.00689	CbGeAlD
Crizotinib—MAP4K5—trigeminal ganglion—periodontitis	0.000726	0.00672	CbGeAlD
Crizotinib—MAP3K3—trigeminal ganglion—periodontitis	0.000726	0.00672	CbGeAlD
Crizotinib—TEK—trigeminal ganglion—periodontitis	0.000726	0.00672	CbGeAlD
Crizotinib—SLK—parotid gland—periodontitis	0.000721	0.00667	CbGeAlD
Crizotinib—EPHB4—parotid gland—periodontitis	0.000716	0.00662	CbGeAlD
Crizotinib—RIPK2—epithelium—periodontitis	0.000707	0.00655	CbGeAlD
Crizotinib—MAP3K2—connective tissue—periodontitis	0.000706	0.00654	CbGeAlD
Crizotinib—EPHA2—parotid gland—periodontitis	0.000702	0.00649	CbGeAlD
Crizotinib—EPHB6—trigeminal ganglion—periodontitis	0.000694	0.00642	CbGeAlD
Crizotinib—PTK2—connective tissue—periodontitis	0.000692	0.0064	CbGeAlD
Crizotinib—TYK2—connective tissue—periodontitis	0.000687	0.00636	CbGeAlD
Crizotinib—MAP4K5—parotid gland—periodontitis	0.000685	0.00634	CbGeAlD
Crizotinib—MAP3K3—parotid gland—periodontitis	0.000685	0.00634	CbGeAlD
Crizotinib—YES1—trigeminal ganglion—periodontitis	0.00067	0.0062	CbGeAlD
Crizotinib—RPS6KB1—connective tissue—periodontitis	0.000666	0.00616	CbGeAlD
Crizotinib—STK10—trigeminal ganglion—periodontitis	0.000664	0.00615	CbGeAlD
Crizotinib—TAOK3—trigeminal ganglion—periodontitis	0.000662	0.00612	CbGeAlD
Crizotinib—AXL—connective tissue—periodontitis	0.000659	0.0061	CbGeAlD
Crizotinib—PTK2—epithelium—periodontitis	0.000657	0.00608	CbGeAlD
Crizotinib—EPHB6—parotid gland—periodontitis	0.000654	0.00605	CbGeAlD
Crizotinib—YES1—parotid gland—periodontitis	0.000632	0.00585	CbGeAlD
Crizotinib—RPS6KB1—epithelium—periodontitis	0.000632	0.00585	CbGeAlD
Crizotinib—EPHB4—connective tissue—periodontitis	0.00063	0.00583	CbGeAlD
Crizotinib—JAK2—connective tissue—periodontitis	0.000625	0.00578	CbGeAlD
Crizotinib—TAOK3—parotid gland—periodontitis	0.000624	0.00578	CbGeAlD
Crizotinib—TEK—connective tissue—periodontitis	0.000603	0.00558	CbGeAlD
Crizotinib—EPHB4—epithelium—periodontitis	0.000598	0.00553	CbGeAlD
Crizotinib—JAK2—epithelium—periodontitis	0.000594	0.00549	CbGeAlD
Crizotinib—EPHA2—epithelium—periodontitis	0.000586	0.00543	CbGeAlD
Crizotinib—CSF1R—trigeminal ganglion—periodontitis	0.000579	0.00536	CbGeAlD
Crizotinib—TEK—epithelium—periodontitis	0.000572	0.00529	CbGeAlD
Crizotinib—YES1—connective tissue—periodontitis	0.000557	0.00515	CbGeAlD
Crizotinib—TAOK3—connective tissue—periodontitis	0.000549	0.00508	CbGeAlD
Crizotinib—SRC—connective tissue—periodontitis	0.000535	0.00495	CbGeAlD
Crizotinib—SRC—epithelium—periodontitis	0.000508	0.0047	CbGeAlD
Crizotinib—CSF1R—connective tissue—periodontitis	0.000481	0.00445	CbGeAlD
Crizotinib—ABL1—trigeminal ganglion—periodontitis	0.000458	0.00424	CbGeAlD
Crizotinib—ABL1—parotid gland—periodontitis	0.000432	0.00399	CbGeAlD
Crizotinib—ABL1—connective tissue—periodontitis	0.00038	0.00352	CbGeAlD
Crizotinib—ABCB1—trigeminal ganglion—periodontitis	0.000142	0.00132	CbGeAlD
Crizotinib—ABCB1—epithelium—periodontitis	0.000112	0.00104	CbGeAlD
Crizotinib—SRC—Immune System—CD14—periodontitis	6.5e-06	3.79e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—FGF2—periodontitis	6.48e-06	3.77e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MMP3—periodontitis	6.47e-06	3.77e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CCR2—periodontitis	6.47e-06	3.77e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CXCR2—periodontitis	6.45e-06	3.76e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—ADRB1—periodontitis	6.44e-06	3.75e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—FGF2—periodontitis	6.43e-06	3.75e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—MMP9—periodontitis	6.41e-06	3.74e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—CRP—periodontitis	6.41e-06	3.73e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—FGF2—periodontitis	6.39e-06	3.72e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CRP—periodontitis	6.38e-06	3.72e-05	CbGpPWpGaD
Crizotinib—LYN—Axon guidance—IL6—periodontitis	6.37e-06	3.72e-05	CbGpPWpGaD
Crizotinib—ABL1—Axon guidance—IL6—periodontitis	6.34e-06	3.7e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL1A—periodontitis	6.28e-06	3.66e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—VCAM1—periodontitis	6.27e-06	3.66e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL18—periodontitis	6.27e-06	3.65e-05	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—IL6—periodontitis	6.19e-06	3.61e-05	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—IL6—periodontitis	6.16e-06	3.59e-05	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—IL6—periodontitis	6.16e-06	3.59e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—TLR4—periodontitis	6.14e-06	3.58e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—TLR4—periodontitis	6.11e-06	3.56e-05	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—IL6—periodontitis	6.1e-06	3.56e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—IFNG—periodontitis	6.09e-06	3.55e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—FGF2—periodontitis	6.06e-06	3.53e-05	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—TGFB1—periodontitis	6.04e-06	3.52e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—AGER—periodontitis	6.02e-06	3.51e-05	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—TGFB1—periodontitis	6.01e-06	3.5e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—IFNG—periodontitis	6.01e-06	3.5e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CRP—periodontitis	5.99e-06	3.49e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—FGF2—periodontitis	5.99e-06	3.49e-05	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—TGFB1—periodontitis	5.97e-06	3.48e-05	CbGpPWpGaD
Crizotinib—JAK2—Axon guidance—IL6—periodontitis	5.97e-06	3.48e-05	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—IL6—periodontitis	5.94e-06	3.46e-05	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—IL6—periodontitis	5.94e-06	3.46e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—FGF2—periodontitis	5.93e-06	3.46e-05	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—TGFB1—periodontitis	5.92e-06	3.45e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—CCL2—periodontitis	5.9e-06	3.44e-05	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—TGFB1—periodontitis	5.89e-06	3.44e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—FGF2—periodontitis	5.88e-06	3.43e-05	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—IL6—periodontitis	5.87e-06	3.42e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—CCL2—periodontitis	5.82e-06	3.39e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling by NGF—IL6—periodontitis	5.77e-06	3.37e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SLC52A3—periodontitis	5.76e-06	3.36e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—TLR4—periodontitis	5.75e-06	3.35e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IFNG—periodontitis	5.7e-06	3.32e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—FGF2—periodontitis	5.7e-06	3.32e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCR2—periodontitis	5.67e-06	3.3e-05	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—TGFB1—periodontitis	5.65e-06	3.29e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—ADRB1—periodontitis	5.64e-06	3.29e-05	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—TNF—periodontitis	5.64e-06	3.29e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NTRK1—periodontitis	5.64e-06	3.29e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—CXCL8—periodontitis	5.63e-06	3.28e-05	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—IL6—periodontitis	5.63e-06	3.28e-05	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—IL6—periodontitis	5.62e-06	3.27e-05	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—TNF—periodontitis	5.61e-06	3.27e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—CCL2—periodontitis	5.57e-06	3.25e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL1A—periodontitis	5.56e-06	3.24e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL18—periodontitis	5.55e-06	3.24e-05	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	5.54e-06	3.23e-05	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—TGFB1—periodontitis	5.54e-06	3.23e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IFNG—periodontitis	5.53e-06	3.22e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ACP5—periodontitis	5.51e-06	3.21e-05	CbGpPWpGaD
Crizotinib—PTK2—Innate Immune System—IL6—periodontitis	5.46e-06	3.18e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—IL1B—periodontitis	5.43e-06	3.17e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—FGF2—periodontitis	5.43e-06	3.16e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CCL2—periodontitis	5.4e-06	3.15e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—TGFB1—periodontitis	5.4e-06	3.15e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—CCL2—periodontitis	5.4e-06	3.15e-05	CbGpPWpGaD
Crizotinib—YES1—Innate Immune System—IL6—periodontitis	5.39e-06	3.14e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—IL1B—periodontitis	5.36e-06	3.12e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—FGF2—periodontitis	5.34e-06	3.11e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—AGER—periodontitis	5.33e-06	3.11e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—MMP9—periodontitis	5.31e-06	3.1e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—TGFB1—periodontitis	5.28e-06	3.08e-05	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—TNF—periodontitis	5.27e-06	3.08e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NTRK1—periodontitis	5.27e-06	3.07e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—FGF2—periodontitis	5.26e-06	3.07e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CRP—periodontitis	5.25e-06	3.06e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MMP3—periodontitis	5.24e-06	3.05e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—CXCL8—periodontitis	5.24e-06	3.05e-05	CbGpPWpGaD
Crizotinib—CDK7—Disease—TGFB1—periodontitis	5.21e-06	3.04e-05	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	5.18e-06	3.02e-05	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—IL6—periodontitis	5.15e-06	3e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling by NGF—IL6—periodontitis	5.11e-06	2.98e-05	CbGpPWpGaD
Crizotinib—IRAK1—Innate Immune System—IL6—periodontitis	5.11e-06	2.98e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IL1B—periodontitis	5.08e-06	2.96e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—NOS2—periodontitis	5.05e-06	2.94e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—TLR4—periodontitis	5.03e-06	2.93e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—FGF2—periodontitis	5.03e-06	2.93e-05	CbGpPWpGaD
Crizotinib—TBK1—Immune System—IL6—periodontitis	5.03e-06	2.93e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCR2—periodontitis	5.02e-06	2.92e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—ADRB1—periodontitis	4.99e-06	2.91e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—IL6—periodontitis	4.98e-06	2.9e-05	CbGpPWpGaD
Crizotinib—TYK2—Innate Immune System—IL6—periodontitis	4.96e-06	2.89e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IL1B—periodontitis	4.93e-06	2.88e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MMP3—periodontitis	4.9e-06	2.86e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—PTGS2—periodontitis	4.9e-06	2.85e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—FGF2—periodontitis	4.88e-06	2.84e-05	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—TGFB1—periodontitis	4.85e-06	2.83e-05	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—IL6—periodontitis	4.82e-06	2.81e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—FGF2—periodontitis	4.76e-06	2.78e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—FGF2—periodontitis	4.74e-06	2.76e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—MMP9—periodontitis	4.74e-06	2.76e-05	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—CXCL8—periodontitis	4.7e-06	2.74e-05	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	4.68e-06	2.73e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—CXCL8—periodontitis	4.67e-06	2.72e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CRP—periodontitis	4.65e-06	2.71e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CCL2—periodontitis	4.63e-06	2.7e-05	CbGpPWpGaD
Crizotinib—SRC—Axon guidance—IL6—periodontitis	4.63e-06	2.7e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NTRK1—periodontitis	4.62e-06	2.69e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—CXCL8—periodontitis	4.6e-06	2.68e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CCL2—periodontitis	4.57e-06	2.66e-05	CbGpPWpGaD
Crizotinib—JAK3—Immune System—IL6—periodontitis	4.55e-06	2.65e-05	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—IL6—periodontitis	4.55e-06	2.65e-05	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—IL6—periodontitis	4.53e-06	2.64e-05	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—IL6—periodontitis	4.5e-06	2.62e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—IFNG—periodontitis	4.48e-06	2.61e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IFNG—periodontitis	4.46e-06	2.6e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—TLR4—periodontitis	4.46e-06	2.6e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—FGF2—periodontitis	4.46e-06	2.6e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—NOS2—periodontitis	4.42e-06	2.58e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—CXCL8—periodontitis	4.4e-06	2.57e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TGFB1—periodontitis	4.38e-06	2.55e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CCL2—periodontitis	4.33e-06	2.53e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—TGFB1—periodontitis	4.3e-06	2.51e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MMP3—periodontitis	4.29e-06	2.5e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CXCL8—periodontitis	4.27e-06	2.49e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—CXCL8—periodontitis	4.27e-06	2.49e-05	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—IL6—periodontitis	4.26e-06	2.48e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—MMP9—periodontitis	4.22e-06	2.46e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CCL2—periodontitis	4.21e-06	2.45e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IFNG—periodontitis	4.19e-06	2.44e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—FGF2—periodontitis	4.19e-06	2.44e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—MMP9—periodontitis	4.16e-06	2.43e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—FGF2—periodontitis	4.13e-06	2.41e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—FGF2—periodontitis	4.11e-06	2.4e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TNF—periodontitis	4.09e-06	2.38e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NTRK1—periodontitis	4.09e-06	2.38e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—IL6—periodontitis	4.07e-06	2.37e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GGT1—periodontitis	4.06e-06	2.37e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—IL6—periodontitis	4.05e-06	2.36e-05	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—IL6—periodontitis	4.02e-06	2.34e-05	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—IL6—periodontitis	4e-06	2.33e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—IL6—periodontitis	4e-06	2.33e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL1B—periodontitis	4e-06	2.33e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—MMP9—periodontitis	3.98e-06	2.32e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—IL6—periodontitis	3.98e-06	2.32e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL1B—periodontitis	3.98e-06	2.32e-05	CbGpPWpGaD
Crizotinib—CDK7—Disease—IL6—periodontitis	3.92e-06	2.29e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—FGF2—periodontitis	3.92e-06	2.28e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—NOS2—periodontitis	3.91e-06	2.28e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TGFB1—periodontitis	3.9e-06	2.28e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—FGF2—periodontitis	3.9e-06	2.28e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—IL6—periodontitis	3.9e-06	2.27e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—IL6—periodontitis	3.89e-06	2.27e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—MMP9—periodontitis	3.86e-06	2.25e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—FGF2—periodontitis	3.8e-06	2.22e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MMP3—periodontitis	3.8e-06	2.22e-05	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—IL6—periodontitis	3.76e-06	2.19e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL1B—periodontitis	3.74e-06	2.18e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—PTGS2—periodontitis	3.71e-06	2.16e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—IFNG—periodontitis	3.67e-06	2.14e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CXCL8—periodontitis	3.66e-06	2.14e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CXCL8—periodontitis	3.61e-06	2.11e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—FGF2—periodontitis	3.6e-06	2.1e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—TGFB1—periodontitis	3.54e-06	2.06e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TGFB1—periodontitis	3.48e-06	2.03e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—FGF2—periodontitis	3.46e-06	2.01e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TGFB1—periodontitis	3.43e-06	2e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CXCL8—periodontitis	3.43e-06	2e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CCL2—periodontitis	3.41e-06	1.99e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ACP5—periodontitis	3.39e-06	1.98e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CXCL8—periodontitis	3.33e-06	1.94e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—MMP9—periodontitis	3.31e-06	1.93e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—IL6—periodontitis	3.3e-06	1.92e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—IL6—periodontitis	3.29e-06	1.92e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TGFB1—periodontitis	3.28e-06	1.91e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL1B—periodontitis	3.28e-06	1.91e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MMP9—periodontitis	3.27e-06	1.9e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—IFNG—periodontitis	3.25e-06	1.9e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—PTGS2—periodontitis	3.25e-06	1.89e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—FGF2—periodontitis	3.19e-06	1.86e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CCL2—periodontitis	3.19e-06	1.86e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TGFB1—periodontitis	3.18e-06	1.86e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—IL6—periodontitis	3.18e-06	1.86e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—IL6—periodontitis	3.16e-06	1.84e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—IL6—periodontitis	3.14e-06	1.83e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MMP9—periodontitis	3.1e-06	1.81e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—FGF2—periodontitis	3.08e-06	1.79e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GGT1—periodontitis	3.06e-06	1.79e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MMP9—periodontitis	3.01e-06	1.75e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IL6—periodontitis	2.98e-06	1.74e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—IL6—periodontitis	2.94e-06	1.71e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—IL6—periodontitis	2.92e-06	1.7e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PPARA—periodontitis	2.91e-06	1.69e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL1B—periodontitis	2.9e-06	1.69e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IL6—periodontitis	2.89e-06	1.68e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—FGF2—periodontitis	2.88e-06	1.68e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—PTGS2—periodontitis	2.88e-06	1.68e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCL2—periodontitis	2.79e-06	1.63e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TGFB1—periodontitis	2.73e-06	1.59e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CXCL8—periodontitis	2.69e-06	1.57e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TGFB1—periodontitis	2.69e-06	1.57e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—TGFB1—periodontitis	2.68e-06	1.56e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—IL6—periodontitis	2.67e-06	1.56e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—IL6—periodontitis	2.62e-06	1.53e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—IL6—periodontitis	2.58e-06	1.51e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TGFB1—periodontitis	2.55e-06	1.49e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—FGF2—periodontitis	2.52e-06	1.47e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CXCL8—periodontitis	2.52e-06	1.47e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TGFB1—periodontitis	2.48e-06	1.45e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—IL6—periodontitis	2.47e-06	1.44e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCL2—periodontitis	2.47e-06	1.44e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MMP9—periodontitis	2.44e-06	1.42e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—IL6—periodontitis	2.4e-06	1.4e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—IL6—periodontitis	2.4e-06	1.4e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—TGFB1—periodontitis	2.35e-06	1.37e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL6—periodontitis	2.34e-06	1.36e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL6—periodontitis	2.33e-06	1.36e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MMP9—periodontitis	2.28e-06	1.33e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—FGF2—periodontitis	2.23e-06	1.3e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CXCL8—periodontitis	2.21e-06	1.29e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PPARA—periodontitis	2.19e-06	1.28e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL6—periodontitis	2.19e-06	1.28e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—TGFB1—periodontitis	2.08e-06	1.21e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL6—periodontitis	2.06e-06	1.2e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL6—periodontitis	2.03e-06	1.18e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—IL6—periodontitis	2.02e-06	1.18e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TGFB1—periodontitis	2.01e-06	1.17e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MMP9—periodontitis	2e-06	1.16e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CXCL8—periodontitis	1.95e-06	1.14e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL6—periodontitis	1.92e-06	1.12e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL6—periodontitis	1.92e-06	1.12e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PTGS2—periodontitis	1.89e-06	1.1e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GGT1—periodontitis	1.89e-06	1.1e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TGFB1—periodontitis	1.88e-06	1.1e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL6—periodontitis	1.87e-06	1.09e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—IL6—periodontitis	1.77e-06	1.03e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MMP9—periodontitis	1.77e-06	1.03e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL6—periodontitis	1.7e-06	9.9e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TGFB1—periodontitis	1.65e-06	9.59e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—IL6—periodontitis	1.57e-06	9.14e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL6—periodontitis	1.51e-06	8.82e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TGFB1—periodontitis	1.46e-06	8.49e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTGS2—periodontitis	1.43e-06	8.31e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL6—periodontitis	1.42e-06	8.25e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PPARA—periodontitis	1.35e-06	7.88e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL6—periodontitis	1.24e-06	7.23e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL6—periodontitis	1.1e-06	6.4e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTGS2—periodontitis	8.78e-07	5.12e-06	CbGpPWpGaD
